These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37379732)

  • 1. Global inequities in access to COVID-19 health products and technologies: A political economy analysis.
    Gleeson D; Townsend B; Tenni BF; Phillips T
    Health Place; 2023 Sep; 83():103051. PubMed ID: 37379732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we move beyond vaccine apartheid? Examining the determinants of the COVID-19 vaccine gap.
    Forman L; Jackson C; Fajber K
    Glob Public Health; 2023 Jan; 18(1):2256822. PubMed ID: 37715686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders.
    Kohler J; Wong A; Tailor L
    Health Hum Rights; 2022 Dec; 24(2):159-175. PubMed ID: 36579316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity.
    Louden EM
    Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How extractive industries affect health: Political economy underpinnings and pathways.
    Schrecker T; Birn AE; Aguilera M
    Health Place; 2018 Jul; 52():135-147. PubMed ID: 29886130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solidarity across borders: A pragmatic need for global COVID-19 vaccine equity.
    Obinna DN
    Int J Health Plann Manage; 2022 Jan; 37(1):21-29. PubMed ID: 34585430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Market Failure, State Failure: The Political Economy of Supply Chain Strengthening to Ensure Equitable Access to Vaccines and Medicines in Low- and Middle-Income Countries.
    Fox A
    J Health Polit Policy Law; 2024 Feb; 49(1):43-72. PubMed ID: 37522368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVAX, vaccine donations and the politics of global vaccine inequity.
    de Bengy Puyvallée A; Storeng KT
    Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis.
    Krikorian G; Torreele E
    Health Hum Rights; 2021 Jun; 23(1):119-127. PubMed ID: 34194206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing how global health partnerships function: an equity-informed critical interpretive synthesis.
    Plamondon KM; Brisbois B; Dubent L; Larson CP
    Global Health; 2021 Jul; 17(1):73. PubMed ID: 34215301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVAX and equitable access to COVID-19 vaccines.
    Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
    Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Business as Usual? Centering Human Rights to Advance Global COVID-19 Vaccine Equity Through COVAX.
    Fajber K
    Health Hum Rights; 2022 Dec; 24(2):219-228. PubMed ID: 36579321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Things That Become Visible, for a While, Can Leave a Residue Comment on "Ensuring Global Health Equity in a Post-pandemic Economy".
    Jensen N
    Int J Health Policy Manag; 2023; 12():7756. PubMed ID: 37579481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
    Hassan MA; Aliyu S
    Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.
    Amin T; Kesselheim AS
    Inquiry; 2022; 59():469580221124821. PubMed ID: 36124939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racism and the Political Economy of COVID-19: Will We Continue to Resurrect the Past?
    Bailey ZD; Moon JR
    J Health Polit Policy Law; 2020 Dec; 45(6):937-950. PubMed ID: 32464657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic.
    Altindis E
    Expert Rev Vaccines; 2022 Apr; 21(4):427-430. PubMed ID: 34878957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.